R. H. Perry

8.8k total citations · 1 hit paper
30 papers, 2.9k citations indexed

About

R. H. Perry is a scholar working on Neurology, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, R. H. Perry has authored 30 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 9 papers in Molecular Biology and 9 papers in Psychiatry and Mental health. Recurrent topics in R. H. Perry's work include Dementia and Cognitive Impairment Research (9 papers), Parkinson's Disease Mechanisms and Treatments (9 papers) and Alzheimer's disease research and treatments (7 papers). R. H. Perry is often cited by papers focused on Dementia and Cognitive Impairment Research (9 papers), Parkinson's Disease Mechanisms and Treatments (9 papers) and Alzheimer's disease research and treatments (7 papers). R. H. Perry collaborates with scholars based in United Kingdom, United States and France. R. H. Perry's co-authors include Ian G. McKeith, Elaine K. Perry, G. Blessed, Andrew Fairbairn, B. E. Tomlinson, Paul M. Thompson, Elizabeth A. Perry, Paul G. Ince, I. N. Ferrier and E K Perry and has published in prestigious journals such as Neurology, Biological Psychiatry and Radiology.

In The Last Decade

R. H. Perry

30 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CHANGES IN BRAIN CHOLINESTERASES IN SENILE DEMENTIA OF ALZHEIMER TYPE

1978 469 citations Elaine K. Perry, R. H. Perry et al. Neuropathology and Applied Neurobiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. H. Perry United Kingdom	20	878	873	848	667	579	30	2.9k
H. Robert Brashear United States	30	949 1.1×	906 1.0×	1.5k 1.7×	718 1.1×	555 1.0×	86	3.8k
Douglas Galasko United States	18	785 0.9×	1.2k 1.3×	1.4k 1.6×	739 1.1×	404 0.7×	32	3.0k
Hitoshi Shinotoh Japan	31	1.4k 1.6×	681 0.8×	878 1.0×	490 0.7×	587 1.0×	109	3.4k
Ronald J. Polinsky United States	29	703 0.8×	396 0.5×	980 1.2×	831 1.2×	397 0.7×	75	3.2k
Douglas Galasko United States	27	613 0.7×	1.5k 1.8×	1.7k 2.1×	487 0.7×	332 0.6×	45	3.3k
Pietro Tiraboschi Italy	24	926 1.1×	985 1.1×	1.1k 1.3×	376 0.6×	272 0.5×	69	2.7k
Thomas Leyhe Germany	33	562 0.6×	1.1k 1.2×	1.7k 2.0×	642 1.0×	419 0.7×	95	4.0k
Ravi Anand United States	24	855 1.0×	1.2k 1.4×	593 0.7×	162 0.2×	883 1.5×	39	2.7k
C. G. Gottfries Sweden	30	615 0.7×	856 1.0×	918 1.1×	514 0.8×	497 0.9×	64	3.3k
Margaret A. Piggott United Kingdom	28	662 0.8×	407 0.5×	666 0.8×	1.3k 2.0×	669 1.2×	55	2.9k

Countries citing papers authored by R. H. Perry

Since Specialization

Citations

This map shows the geographic impact of R. H. Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. H. Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. H. Perry more than expected).

Fields of papers citing papers by R. H. Perry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. H. Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. H. Perry. The network helps show where R. H. Perry may publish in the future.

Co-authorship network of co-authors of R. H. Perry

This figure shows the co-authorship network connecting the top 25 collaborators of R. H. Perry. A scholar is included among the top collaborators of R. H. Perry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. H. Perry. R. H. Perry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Perry, R. H., et al.. (2025). Feasibility of Auditing Preoperative Breast MRI for Extent-of-Disease Evaluation Using the BI-RADS v2025 Manual. Radiology. 317(1). e243803–e243803. 1 indexed citations

Davidson, Yvonne S., Andrew Robinson, Hu Q, et al.. (2012). Nuclear carrier and RNA‐binding proteins in frontotemporal lobar degeneration associated with fused in sarcoma (FUS) pathological changes. Neuropathology and Applied Neurobiology. 39(2). 157–165. 30 indexed citations

Ballard, Clive, Ian G. McKeith, David J. Burn, et al.. (2009). The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies. Acta Neurologica Scandinavica. 96(6). 366–371. 34 indexed citations

Tasker, Andrea, Clive Ballard, Catharine Joachim, et al.. (2008). Butyrylcholinesterase K variant associated with higher enzyme activity in the temporal cortex of elderly patients. Neuroscience Letters. 442(3). 297–299. 10 indexed citations

Betts, Joanne, Evelyn Jaros, R. H. Perry, et al.. (2006). Molecular neuropathology of MELAS: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement. Neuropathology and Applied Neurobiology. 32(4). 359–373. 112 indexed citations

Ballard, Clive, I. Ziabreva, R. H. Perry, et al.. (2006). Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology. 67(11). 1931–1934. 244 indexed citations

Fernando, Malee, John T. O’Brien, R. H. Perry, et al.. (2004). Comparison of the pathology of cerebral white matter with post‐mortem magnetic resonance imaging (MRI) in the elderly brain. Neuropathology and Applied Neurobiology. 30(4). 385–395. 111 indexed citations

Perry, R. H., et al.. (2002). A new dementia: Neurofilament inclusion body dementia. Journal of Neuropathology & Experimental Neurology. 6 indexed citations

Abravaya, Klara, Gregor Leckie, R. H. Perry, et al.. (2001). A new ultrasensitive assay for quantitation of HIV-1 RNA in plasma. Journal of Virological Methods. 95(1-2). 81–92. 35 indexed citations

10.

Ballard, Clive, G. Ayre, John T. O’Brien, et al.. (1999). Simple Standardised NeuropsychologicalAssessments Aid in the Differential Diagnosis of Dementia with Lewy Bodies from Alzheimer’s Disease and Vascular Dementia. Dementia and Geriatric Cognitive Disorders. 10(2). 104–108. 61 indexed citations

11.

Thompson, J., Natalie Thomas, Andrew Singleton, et al.. (1997). D2 dopamine receptor gene (DRD2) Taql A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics. 7(6). 479–484. 476 indexed citations

12.

Marshall, Elizabeth F., R. H. Perry, Elaine K. Perry, et al.. (1997). Striatal dopaminergic loss without parkinsonism in a case of corticobasal degeneration. Acta Neurologica Scandinavica. 95(5). 287–292. 1 indexed citations

13.

Edwards, Richard, Stephen M. Gentleman, Paul G. Ince, et al.. (1996). A quantitative comparison of plaque types in Alzheimer's disease and senile dementia of the Lewy body type. Acta Neuropathologica. 91(5). 526–529. 16 indexed citations

14.

Griffiths, P. D., R. H. Perry, & Alan R. Crossman. (1994). A detailed anatomical analysis of neurotransmitter receptors in the putamen and caudate in Parkinson's disease and Alzheimer's disease. Neuroscience Letters. 169(1-2). 68–72. 44 indexed citations

15.

McKeith, Ian G., Andrew Fairbairn, P. Brian Moore, et al.. (1994). An evaluation of the predictive validity and inter‐rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology. 44(5). 872–872. 142 indexed citations

16.

Gentleman, Stephen M., Ben Williams, M.C. Royston, et al.. (1992). Quantification of βA4 protein deposition in the medial temporal lobe: A comparison of Alzheimer's disease and senile dementia of the Lewy body type. Neuroscience Letters. 142(1). 9–12. 23 indexed citations

17.

Kerwin, Janet, Christopher M. Morris, R. H. Perry, & Elaine K. Perry. (1992). Hippocampal nerve growth factor receptor immunoreactivity in patients with Alzheimer's and Parkinson's disease. Neuroscience Letters. 143(1-2). 101–104. 20 indexed citations

18.

Ince, Paul G., et al.. (1991). Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: Comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients. Journal of the Neurological Sciences. 106(2). 142–152. 69 indexed citations

19.

Perry, Elaine K., R. H. Perry, D J Dick, et al.. (1987). Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases.. Journal of Neurology Neurosurgery & Psychiatry. 50(6). 806–809. 139 indexed citations

20.

Taylor, George R., et al.. (1985). Measurement of relative concentrations of rna in post mortem brains from senile dementia of the alzheimer type and controls. Journal of Neurogenetics. 2(2). 177. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact